Tirzepatide mushonga mutsva unomiririra kubudirira kukuru mukurapa kwerudzi rwechipiri chirwere cheshuga uye kufutisa. Ndiyo yekutanga mbiri agonist yeglucose-inotsamira insulinotropic polypeptide (GIP) uye glucagon-like peptide-1 (GLP-1) receptors. Iyi yakasarudzika nzira yekuita inoiisa parutivi kubva kune iripo marapirwo uye inogonesa mhedzisiro yakasimba pane ese eropa kutonga kweglucose uye kuderedza uremu.
Nekuita GIP uye GLP-1 receptors, Tirzepatide inowedzera insulin secretion uye sensitivity, inoderedza glucagon secretion, inononoka kubuda mudumbu, uye inoderedza kudya.
Inodzorwa senge kamwe-vhiki nevhiki subcutaneous jekiseni, Tirzepatide yakaratidza kushanda kunoshamisa mumakiriniki miedzo. Iyo inovandudza zvakanyanya glycemic control uye inoderedza uremu hwemuviri, kazhinji inodarika kushanda kwemishonga iripo ikozvino. Uyezve, zvinogona kubatsira zvemoyo zvakaonekwa.
Mishonga inonyanyozivikanwa ndeyekuita gastrointestinal, kusanganisira kusvotwa, manyoka, uye kurutsa, izvo zvinowanzoitika zvakapfava kusvika pakati pekuomarara uye zvinowanzodzikira nekufamba kwenguva.
Pakazere, kuvandudzwa kweTirzepatide kunoratidza muganho mutsva mukurapa kwezvirwere zvemetabolism, ichipa chishandiso chine simba chekugadzirisa zvese chirwere cheshuga uye kufutisa.
Nguva yekutumira: Sep-01-2025